Evidence map›Paper›PMID 40082609›Full record

ArticleNature methods2025

Optimizing Xenium In Situ data utility by quality assessment and best-practice analysis workflows.

Sergio Marco Salas, Louis B Kuemmerle, Christoffer Mattsson-Langseth, Sebastian Tismeyer, Christophe Avenel, Taobo Hu, Habib Rehman, Marco Grillo, Paulo Czarnewski, Saga Helgadottir and 9 more

Abstract read
In one paragraph

Article in Nature methods, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 131 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
131citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

131 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Insights Into Spatial Transcriptomics: Exploring Recent Technical Developments and Their Diverse Applications.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

71 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Sergio Marco SalasScience for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden. sergiomarco.salas@scilifelab.se.ORCID http://orcid.org/0000-0002-4636-0322
Louis B Kuemmerle *Institute of Computational Biology, Computational Health Center, Helmholtz Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-9193-1243
Christoffer Mattsson-Langseth *Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.
Sebastian Tismeyer *Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Digital Health Center, Berlin, Germany.
Christophe Avenel *Department of Information Technology and SciLifeLab BioImage Informatics Facility, Uppsala University, Uppsala, Sweden.ORCID http://orcid.org/0000-0002-1835-921X
Taobo Hu *Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.ORCID http://orcid.org/0000-0001-5124-7167
Habib Rehman *Institute of Computational Biology, Computational Health Center, Helmholtz Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-8671-982X
Marco Grillo *Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.ORCID http://orcid.org/0000-0003-2155-0645
Paulo Czarnewski *Science for Life Laboratory, Department of Gene Technology, KTH Royal Institute of Technology, Stockholm, Sweden.
Saga Helgadottir *Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.
Katarina TiklovaScience for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.
Axel AnderssonDepartment of Information Technology and SciLifeLab BioImage Informatics Facility, Uppsala University, Uppsala, Sweden.ORCID http://orcid.org/0000-0002-4714-3127
Nima RafatiNational Bioinformatics Infrastructure Sweden, Uppsala University, SciLifeLab, Department of Medical Biochemistry and Microbiology, Uppsala, Sweden.
Maria ChatzinikolaouScience for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.
Fabian J TheisInstitute of Computational Biology, Computational Health Center, Helmholtz Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-2419-1943
Malte D LueckenInstitute of Computational Biology, Computational Health Center, Helmholtz Munich, Munich, Germany.ORCID http://orcid.org/0000-0001-7464-7921
Carolina WählbyDepartment of Information Technology and SciLifeLab BioImage Informatics Facility, Uppsala University, Uppsala, Sweden.ORCID http://orcid.org/0000-0002-4139-7003
Naveed IshaqueBerlin Institute of Health at Charité - Universitätsmedizin Berlin, Digital Health Center, Berlin, Germany.ORCID http://orcid.org/0000-0002-8426-901X
Mats NilssonScience for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden. mats.nilsson@scilifelab.se.ORCID http://orcid.org/0000-0001-9985-0387

Funding

Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) FKZ: 031L0265Cancerfonden (Swedish Cancer Society) CAN 2018/604Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation) KAW 2018.0172Vetenskapsrådet (Swedish Research Council) 2019-01238
6 · The paper itself

Abstract

The Xenium In Situ platform is a new spatial transcriptomics product commercialized by 10x Genomics, capable of mapping hundreds of genes in situ at subcellular resolution. Given the multitude of commercially available spatial transcriptomics technologies, recommendations in choice of platform and analysis guidelines are increasingly important. Herein, we explore 25 Xenium datasets generated from multiple tissues and species, comparing scalability, resolution, data quality, capacities and limitations with eight other spatially resolved transcriptomics technologies and commercial platforms. In addition, we benchmark the performance of multiple open-source computational tools, when applied to Xenium datasets, in tasks including preprocessing, cell segmentation, selection of spatially variable features and domain identification. This study serves as an independent analysis of the performance of Xenium, and provides best practices and recommendations for analysis of such datasets.

Indexed as

Gene Expression ProfilingTranscriptomeAnimalsComputational BiologyGenomicsHumansSoftwareWorkflow

Identifiers

PMID40082609
PMCPMC11978515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.